SATELLOS BIOSCIENCE INC.

Insiders Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Market Closed - Toronto S.E. Other stock markets 01:30:05 2024-04-29 pm EDT			5-day change	1st Jan Change
0.45 ^CAD	-6.25%		-6.25%	+4.65%

Mar. 27	Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 27	Satellos Bioscience Announces FY 2023 Results	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Satellos Bioscience Inc. Brief: Shares Jumped 13.4% on Monday; Co Recently Received Conditional Approval to Graduate to the Toronto Stock Exchange	Jan. 23	MT
Satellos Bioscience Inc. Brief: Announced Earlier Tuesday Management Team Update; Alan K. Jacobs, Chief Medical Officer Has Left to Pursue Other Opportunities; Jordan Dubow Engaged As Chief Medical Advisor	Jan. 23	MT
Satellos Bioscience Inc. Announces Executive Changes	Jan. 23	CI
Satellos Bioscience Inc. Announces Executive Changes	Nov. 22	CI
Satellos Biosciences Provides Update on Duchenne Muscular Dystrophy Program	Nov. 14	MT
Satellos Bioscience Names New CFO; Up 3.8%	23-09-05	MT
Satellos Bioscience Inc. Announces Appointment of Warren Whitehead as Head of Corporate Strategy	23-09-05	CI
Satellos Bioscience Inc. Announces Appointment of Alan K. Jacobs as Chief Medical Officer	23-06-07	CI
Satellos Bioscience Inc. Announces Appointment of Philip D. Lambert as Chief Technology Officer	22-09-28	CI
Satellos Bioscience Inc. Announces Executive Changes	21-12-06	CI
ICo Therapeutics Inc. Announces Executive Changes	21-08-13	CI
ICo Therapeutics Inc. Announces the Resignation of Susan Koppy from the Board of Directors	21-04-29	CI
ICo Therapeutics Inc. Announces Appointment of Kishor Wasan as Director of Research	20-04-15	CI
ICo Therapeutics Inc. Announces Management Changes	20-03-09	CI
ICo Therapeutics Announces Oral Amphotericin B Clinical Advisory Board Appointments	18-10-23	CI
ICo Therapeutics Inc. Approves Board Appointments	17-06-30	CI
ICo Therapeutics Announces Resignation of John Meekison as Chief Financial Officer	16-08-20	CI
Ico Therapeutics Inc. Announces Changes to Board of Directors	15-12-24	CI
ICo Therapeutics Inc. Appoints Douglas G. Janzen to the Board of Directors	12-03-05	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer